Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

Author: Nussenblatt R.B.   Thompson D.J.S.   Li Z.   Peterson J.S.   Robinson R.R.   Shames R.S.   Nagarajan S.   Tang M.T.   Mailman M.   Velez G.   Roy C.   Levy-Clarke G.A.   Suhler E.B.   Djalilian A.   Sen H.N.   Al-Khatib S.   Ursea R.   Srivastava S.   Bamji A.   Mellow S.   Sran P.   Waldmann T.A.   Buggage R.R.  

Publisher: Elsevier

ISSN: 0896-8411

Source: Journal of Autoimmunity, Vol.21, Iss.3, 2003-11, pp. : 283-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content